Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma

Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas

(2012) Hatim Husain et al.   JOURNAL OF NEURO-ONCOLOGY

Exploratory investigation of eight circulating plasma markers in brain tumor patients

(2012) Aysegul Ilhan-Mutlu et al.   NEUROSURGICAL REVIEW

Serum YKL-40 following resection for cerebral glioblastoma

(2011) Daniela Bernardi et al.   JOURNAL OF NEURO-ONCOLOGY

Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas

(2011) Fabio M. Iwamoto et al.   JOURNAL OF NEURO-ONCOLOGY

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

(2011) F. M. Iwamoto et al.   NEURO-ONCOLOGY

Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas

(2009) Yi Lin et al.   NEURO-ONCOLOGY

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE